{
    "eid": "2-s2.0-85066920964",
    "title": "An overview of tolerogenic immunotherapies based on plant-made antigens",
    "cover-date": "2019-06-03",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Clinical Biochemistry",
            "@code": "1308",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "allergy",
        "arthritis",
        "asthma",
        "diabetes",
        "Oral tolerance",
        "regulatory T cell",
        "transgenic plant"
    ],
    "authors": [
        "Dania O. Govea-Alonso",
        "Jaime I. Arevalo-Villalobos",
        "Ver\u00f3nica A. M\u00e1rquez-Escobar",
        "Sornkanok Vimolmangkang",
        "Sergio Rosales-Mendoza"
    ],
    "citedby-count": 0,
    "ref-count": 113,
    "ref-list": [
        "Progress in biopharmaceutical development",
        "Plant-derived pharmaceuticals for the developing world",
        "Principles of plant-based vaccines",
        "Oral immunization by transgenic plants",
        "Engineering viral expression vectors for plants: the \u2018full virus\u2019 and the \u2018deconstructed virus\u2019 strategies",
        "Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic",
        "Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B",
        "A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults",
        "Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment",
        "Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza",
        "Large-scale production of pharmaceutical proteins in plant cell culture-the Protalix experience",
        "Controlled trial of zmapp for ebola virus infection",
        "Oral tolerance development and maintenance",
        "Oral tolerance and allergy",
        "Anatomical basis of tolerance and immunity to intestinal antigens",
        "Allergen immunotherapy: past, present, and future",
        "Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine",
        "Mechanisms underlying induction of tolerance to foods",
        "Intestinal dendritic cells",
        "Immunity and tolerance induced by intestinal mucosal dendritic cells",
        "Intestinal dendritic cells: their role in intestinal inflammation, manipulation by the gut microbiota and differences between mice and men",
        "Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria",
        "Regulatory T cells - a brief history and perspective",
        "Regulatory T cells in autoimmune disease",
        "Regulatory T cells as immunotherapy",
        "Tregs: where we are and what comes next?",
        "Food allergy: a practice parameter update-2014",
        "Allergen immunotherapy",
        "Development of a rice-based peptide vaccine for Japanese cedar and cypress pollen allergies",
        "Allergen immunotherapy",
        "Immunological mechanisms of allergen-specific immunotherapy",
        "Induction of oral tolerance with transgenic plants expressing antigens for prevention/treatment of autoimmune, allergic and inflammatory diseases",
        "Rapid production of the major birch pollen allergen Bet v 1 in Nicotiana benthamiana plants and its immunological in vitro and in vivo characterization",
        "Accumulation of Japanese cedar pollen allergen, Cry j 1, in the protein body I of transgenic rice seeds using the promoter and signal sequence of glutelin GluB-1 gene",
        "Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine",
        "A rice-based edible vaccine expressing multiple T cell epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses",
        "Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens",
        "Deposition of a recombinant peptide in ER-derived protein bodies by retention with cysteine-rich prolamins in transgenic rice seed",
        "Rice seed ER-derived protein body as an efficient delivery vehicle for oral tolerogenic peptides",
        "Construction of a Der p2-transgenic plant for the alleviation of airway inflammation",
        "Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression",
        "Prevalence of asthma-like symptoms in young children",
        "Role of immunotherapy in the treatment of allergic asthma",
        "Role played by Th2 type cytokines in IgE mediated allergy and asthma",
        "Differential regulation of Th1/Th2 cytokine responses by placental protein 14",
        "Cytokines, allergy, and asthma",
        "A plant-based allergy vaccine suppresses experimental asthma via an IFN-gamma and CD4+CD45RBlow T cell-dependent mechanism",
        "Prevention of allergic asthma by vaccination with transgenic rice seed expressing mite allergen: induction of allergen-specific oral tolerance without bystander suppression",
        "Production of a chimeric allergen derived from the major allergen group 1 of house dust mite species in Nicotiana benthamiana",
        "The emerging global epidemic of type 1 diabetes",
        "Epidemiology of type 1 diabetes",
        "Environmental factors associated with childhood-onset type 1 diabetes mellitus: an exploration of the hygiene and overload hypotheses",
        "The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes",
        "Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset",
        "The stages of type 1A diabetes: 2005",
        "Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse",
        "Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease",
        "TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes",
        "NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets",
        "Innate immunity and intestinal microbiota in the development of Type 1 diabetes",
        "Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recent-onset type 1 diabetes",
        "The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes",
        "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus",
        "A plant based-cholera toxin B subunit insulin fusion protein protects against the development of autoimmune diabetes",
        "Transgenic plants expressing human glutamic acid decarboxylase(GAD65), a major autoantigen in insulin-dependent diabetes mellitus",
        "Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65)",
        "Recombinant human GAD65 accumulates to high levels in transgenic tobacco plants when expressed as an enzymatically inactive mutant",
        "Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants",
        "Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4",
        "Enhanced GAD65 production in plants using the MagnICON transient expression system: optimization of upstream production and downstream processing",
        "The pathogenesis of rheumatoid arthritis: new insights from old clinical data?",
        "Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis",
        "Evolving concepts of rheumatoid arthritis",
        "Pathogenetic insights from the treatment of rheumatoid arthritis",
        "Altered peptide ligands control type II collagen-reactive T cells from rheumatoid arthritis patients",
        "Suppression of collagen-induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of type II collagen",
        "Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis",
        "Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis",
        "Suppression of glucose-6-phosphate-isomerase induced arthritis by oral administration of transgenic rice seeds expressing altered peptide ligands of glucose-6-phosphate-isomerase",
        "The hemophilias\u2013from royal genes to gene therapy",
        "Haemophilias A and B",
        "Is haemophilia B less severe than haemophilia A?",
        "Is oral tolerance therapy possible for haemophilia with inhibitors?",
        "Oral delivery of bioencapsulated coagulation factor IX prevents inhibitor formation and fatal anaphylaxis in hemophilia B mice",
        "Plant-based oral tolerance to hemophilia therapy employs a complex immune regulatory response including LAP+CD4+ T cells",
        "Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B",
        "Oral tolerance induction in hemophilia B dogs fed with transplastomic lettuce",
        "Suppression of inhibitor formation against FVIII in a murine model of hemophilia A by oral delivery of antigens bioencapsulated in plant cells",
        "Therapeutic antibodies for autoimmunity and inflammation",
        "IVIG-mediated effector functions in autoimmune and inflammatory diseases",
        "Revisiting IL-2: biology and therapeutic prospects",
        "The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy",
        "Antigen-specific immunotherapies in rheumatic diseases",
        "The future of immunotherapy: a 20 year perspective",
        "Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts: oral administration protects against development of insulitis in non-obese diabetic mice",
        "Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide",
        "Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bio-encapsulation, stability and functional evaluation in vitro",
        "Low-cost oral delivery of protein drugs bioencapsulated in plant cells",
        "When plant virology met Agrobacterium: the rise of the deconstructed clones",
        "Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin\u2019s lymphoma",
        "Production of recombinant antigens and antibodies in Nicotiana benthamiana using \u2018magnifection\u2019 technology: GMP-compliant facilities for small- and large-scale manufacturing",
        "In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants",
        "Plant-made pharmaceuticals: from \u2018Edible Vaccines\u2019 to Ebola therapeutics",
        "Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes",
        "Cell culture media for recombinant protein expression in Chinese hamster ovary (CHO) cells: history, key components, and optimization strategies",
        "Recombinant pharmaceuticals from microbial cells: a 2015 update",
        "Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher\u2019s disease using a plant cell system",
        "Plant-based oral delivery of \u03b2-glucocerebrosidase as an enzyme replacement therapy for Gaucher\u2019s disease",
        "Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp",
        "Antibody production in plants and Green Algae"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Luis Potos\u00ed",
            "@id": "60031335",
            "affilname": "Universidad Aut\u00f3noma de San Luis Potos\u00ed",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031335",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "CONACYT/Mexico",
        "M\u00e9xico",
        "CONACYT"
    ]
}